- Home
- ASGI vs MGTX Comparison
ASGI vs MGTX Comparison
Compare ASGI & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$7.45
Company Overview
Basic Information| Metric | ASGI | MGTX |
|---|---|---|
| Founded | 2019 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 707.1M | 665.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ASGI | MGTX |
|---|---|---|
| Price | $21.93 | $7.45 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $23.83 |
| AVG Volume (30 Days) | 83.3K | ★ 429.0K |
| Earning Date | 01-01-0001 | 11-13-2025 |
| Dividend Yield | ★ 8.76% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,417,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $567.62 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 96.83 |
| 52 Week Low | $14.96 | $4.55 |
| 52 Week High | $18.55 | $9.73 |
Technical Indicators
Market Signals| Indicator | ASGI | MGTX |
|---|---|---|
| Relative Strength Index (RSI) | 51.99 | 43.40 |
| Support Level | $21.25 | $7.00 |
| Resistance Level | $21.78 | $8.08 |
| Average True Range (ATR) | 0.43 | 0.39 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 42.79 | 35.16 |
Price Performance
Historical Comparison ASGI
MGTX
About ASGI abrdn Global Infrastructure Income Fund of Beneficial Interest
abrdn Global Infrastructure Income Fund is a non-diversified, closed-end management investment company. Its objective is to seek to provide a high level of total return with an emphasis on current income by investing in assets that provide necessary services to society.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.